Expression of somatostatin receptor subtypes in human brain tumors

International Journal of Cancer

Volumn 76, Issue 5, 1998, Pages 620-627

  Dutour, Anne ^a   Kumar, Ujendra ^b   Panetta, Rosemarie ^b   Ouafik, L'Hovicine ^a   Fina, Federic ^a   Sasi, Ramakrishnan ^b   Patel, Yogcsh C ^b  

^a HÔPITAL NORD   (France)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; RECEPTOR SUBTYPE; SOMATOSTATIN RECEPTOR;

ARTICLE; BRAIN TUMOR; CONTROLLED STUDY; GENE EXPRESSION; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MENINGIOMA; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODY SPECIFICITY; BLOTTING, NORTHERN; BRAIN NEOPLASMS; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MENINGIOMA; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECEPTORS, SOMATOSTATIN; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0031779094     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980529)76:5<620::AID-IJC2>3.0.CO;2-S     Document Type: Article

References (23)

1. FEINDT, J., KRISCH, B., LUCIUS, R. and MENTLEIN, R., Meningeal cells are targets and inactivation sites for the neuropeptide somatostatin. Brain Res. Mol. Brain Res., 44, 293-300 (1997).
2. HILDEBRANDT, G., SCHEIDHAUER, K., LUYKEN, C., SCHICHA, H., KLUG, N., DAHMUS, P. and KRISCH, B., High sensitivity of the in vivo detection of somatostatin receptors by Indium (DTPA-Octreotide) scintigraphy in meningioma patients. Acta Neurochir., 126, 63-71 (1994).
3. KOPER, J.W., MARKSTEIN, R., KOHLER, C., KWEKKEBOOM, D.J., AVEZAAT, C.J.J., LAMBERTS, S.W.J. and REUBI, J.C., Somatostatin inhibits the activity of adenylate cyclase in cultured human meningioma cells and stimulates their growth. J. clin. Endocrinol. Metab., 74, 543-547 (1992).
4. KUMAR, U., LAIRD, D., SRIKANT, C.B., ESCHER, E. and PATEL, Y.C., Expression of the five somatostatin receptor (SSTR1-5) subtypes in rat pituitary somatotrophes: quantitative analysis by double-label immunofluorescence confocal microscopy. Endocrinology, 138, 4473-4476 (1997).
5. PANETTA, R., GREENWOOD, M.T., WARSZYNSKA, A., DEMCHYSHYN, L., DAY, R., NIZNIK, H.B., SRIKANT, C.B. and PATEL, Y.C., Molecular cloning, functional characterization, and chromosomal localization of a novel human somatostatin receptor (SSTR5) with preferential affinity for somatostatin-28. Mol. Pharmacol., 45, 417-427 (1994).
6. PANETTA, R. and PATEL, Y.C., Expression of mRNA for all 5 human somatostatin receptor (hSSTR1-5) in pituitary tumors. Life Sci., 56, 333-342 (1994).
7. PATEL, Y.C., Molecular pharmacology of somatostatin receptor subtypes. J. Endocrinol. Invest., 20, 348-367 (1997).
8. PATEL, Y.C., GREENWOOD, M.T., KENT, G., PANETTA, R. and SRIKANT, C.B., Multiple gene transcripts of the somatostatin receptor SSTR2: tissue selective distribution and cAMP regulation. Biochem. biophys. Res. Comm., 192, 288-294 (1993).
9. PATEL, Y.C., PANETTA, R., ESCHER, E., GREENWOOD, M.T. and SRIKANT, C.B., Expression of multiple somatostatin receptor genes in AtT-20 cells: evidence for a novel somatostatin-28 selective receptor subtype. J. biol. Chem., 269, 1506-1509 (1994).
10. PINSKI, J., SCHALLY, A.V., HALMOS, G., SZEPESHAZI, K. and GROOT, K., Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo. Cancer Res., 54, 5895-5901 (1994).
11. REICHLIN, S., Somatostatin. N. Engl. J. Med., 309, 1495-1501, 1556-1563 (1983).
12. REISINE, T. and BELL, G.I., Molecular biology of somatostatin receptors. End Rev., 16, 427-442 (1995).
13. REUBI, J.C., Neuropeptide receptors in health and disease: the molecular basis for in vivo imaging. J. nucl. Med,. 36, 1825-1835 (1995).
14. REUBI, J.C., HORISBERGER, U. and LAISSUE, J., High density of somatostatin receptors in veins surrounding human cancer tissue: role in tumor-host interaction? Int. J. Cancer, 56, 681-688 (1994).
15. REUBI, J.C., LANG, W., MAURER, R., KOPER, J.W. and LAMBERTS, S.W.J., Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system. Cancer Res., 47, 5758-5764 (1987).
16. REUBI, J.C., MAURER, R., KLIJN, J.G.M., STEFANKO, S.Z., FOEKENS, J.A., BLAAUW, G., BLANKENSTEIN, M.A. and LAMBERTS, S.W.J,. High incidence of somatostatin receptors in human meningiomas: biochemical characterization. J. clin. Endocrinol. Metab., 63, 433-438 (1986a).
17. REUBI, J.C., MAURER, R. and LAMBERTS, S.W.J., Somatostatin binding sites in human leptomeninx. Neurosci. Lett., 70, 183-186 (1986b).
18. REUBI, J.C., SCHAER, J.C., WASER, B. and MENGOD, G., Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization. Cancer Res., 54, 3455-3459 (1994b).
19. REUBI, J.C., WASER, B., LAMBERTS, S.W.J. and MENGOD, G., Somatostatin (SRIH) messenger ribonuclei acid expression in human neuroendocrine and brain tumors using in situ hybridization histochemistry: comparison with SRIH receptor content. J. clin. Endocrinol. Metab., 76, 642-647 (1993).
20. SCHALLY, A.V., Oncological applications of somatostatin analogues. Cancer Res., 48, 6977-6985 (1988).
21. VANETTI, M., KOUBA, M., WANG, X., VOGT, G. and HOLLT, V., Cloning and expression of a novel mouse somatostatin receptor (SSTR2B). FEBS Lett., 311, 290-294 (1992).
22. WECKBECKER, G., LIU, R., TOLCSVAI, L. and BRUNS, C., Antiproliferative effects of the somatostatin analogue octreotide (SMS201-995) on ZR-75-1 human breast cancer cells in vivo and in vitro. Cancer Res., 52, 4973-1978 (1992).
23. YAMADA, Y., POST, S.R., WANG, K., TAGER, H.S., BELL, G.I. and SEINO, S., Cloning and functional characterizations of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract and kidney. Proc. nat. Acad. Sci. (Wash.), 89, 251-255 (1992).